Type 2 Diabetes Trial, Recruiting NCT06296550 Sponsor: Scripps Whittier Diabetes Institute Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06296550
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with type 2 diabetes
  • People who are not currently using a continuous glucose monitor (a small device that tracks blood sugar levels throughout the day)
  • People who are not using insulin as part of their diabetes treatment
  • People who speak English, Spanish, or Arabic
  • People whose A1c blood sugar level (a measure of average blood sugar over several months) was between 7.5% and 12.0% within the last 90 days
  • People who own a mobile phone that can send and receive text messages and has the ability to count steps

Who may not be able to join:

  • People who are currently using insulin as part of their diabetes treatment
  • People who are pregnant
  • People who are currently using a continuous glucose monitor (a device that tracks blood sugar levels throughout the day)
  • People who are currently taking part in another research study related to diabetes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Athena Philis-Tsimikas, MD, Scripps Health

Phone: 858-258-3555

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Scripps Whittier Diabetes Institute
Registry
ClinicalTrials.gov
Start date
3 April 2025
Est. completion
30 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

HbA1c

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov